The purpose for filing this Form 8-K/A is to correct the disclosure regarding the circumstances of Mr. Turner's departure as CEO of OWC Israel. On April 2, 2017, Mr. Turner submitted his resignation as CEO of OWC Israel to the Registrant. On April 6, 2017, OWC Israel notified Mr. Turner that: (i) his resignation had not been accepted by OWC Israel; and (ii) he had, in fact, been terminated "for cause" as CEO and a director of OWC Israel, effective April 6, 2017.
I wonder exactly what he did...we can speculate..the guy said stupid things repeatedly...that's for sure.
(5)
(1)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links